Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | JAZZ | AZN | AMGN | GILD | VRTX |
| Company | Jazz Pharma Plc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 179.69 | 194.01 | 364.20 | 143.56 | 457.30 |
| High | 183.45 | 194.83 | 369.76 | 144.65 | 460.00 |
| Low | 176.67 | 192.76 | 361.71 | 142.77 | 450.67 |
| Latest | 182.01 | 194.22 | 369.53 | 143.96 | 456.69 |
| Change | -1.62 | -3.30 | +1.93 | -1.18 | -4.13 |
| % Change | -0.88% | -1.67% | +0.53% | -0.81% | -0.90% |
| Volume | 982,661 | 1,473,574 | 2,410,685 | 4,808,175 | 1,169,784 |
| 20-Day Average Volume | 1,097,694 | 2,323,614 | 2,698,596 | 7,512,420 | 1,453,622 |
| Previous Close | 183.63 | 197.52 | 367.60 | 145.14 | 460.82 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 176.35 | 202.44 | 376.06 | 149.85 | 475.36 |
| 20-Day Raw Stochastic | 53.89% | 27.91% | 20.95% | 7.65% | 9.35% |
| 20-Day Relative Strength | 56.50 | 48.14 | 52.65 | 51.58 | 45.49 |
| Weighted Alpha | +39.21 | +30.96 | +21.76 | +30.61 | -2.08 |
| Today's Opinion | 100% Buy | 80% Buy | 88% Buy | 88% Buy | 64% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 88% Buy | 88% Buy | 64% Buy |
| Last Month's Opinion | 40% Buy | 100% Buy | 100% Buy | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.69% since 02/27/26 | -6.83% since 02/27/26 | -5.36% since 02/27/26 | -3.40% since 02/27/26 | -8.24% since 02/27/26 |
| Low | 178.75 on 03/06/26 | 192.81 on 03/06/26 | 361.39 on 03/05/26 | 142.78 on 03/06/26 | 450.95 on 03/06/26 |
| High | 191.54 on 03/02/26 | 206.30 on 03/02/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 498.02 on 03/02/26 |
| 1-Month | |||||
| %Chg | +9.44% since 02/06/26 | +0.62% since 02/06/26 | -4.42% since 02/06/26 | -5.65% since 02/06/26 | -4.61% since 02/06/26 |
| Low | 161.38 on 02/11/26 | 187.06 on 02/09/26 | 361.00 on 02/11/26 | 142.78 on 03/06/26 | 450.95 on 03/06/26 |
| High | 198.00 on 02/26/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| 3-Month | |||||
| %Chg | +6.73% since 12/05/25 | +7.68% since 12/05/25 | +11.35% since 12/05/25 | +18.70% since 12/05/25 | +0.09% since 12/05/25 |
| Low | 156.95 on 01/08/26 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 198.00 on 02/26/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| 6-Month | |||||
| %Chg | +39.86% since 09/05/25 | +18.86% since 09/05/25 | +29.51% since 09/05/25 | +25.07% since 09/05/25 | +15.09% since 09/05/25 |
| Low | 123.88 on 09/15/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 198.00 on 02/26/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,304,264 | 306,335,328 | 198,161,408 | 180,179,840 | 117,063,952 |
| Shares Outstanding, K | 61,560 | 1,550,908 | 539,068 | 1,241,421 | 254,034 |
| Annual Sales | 4,267,590,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -356,150,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 1,197,930,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 3,190,000,000 |
| Last Quarter Net Income | 203,450,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,191,100,000 |
| 60-Month Beta | 0.22 | 0.32 | 0.45 | 0.37 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | 6.64 on 02/24/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 5.03 on 02/12/26 |
| Latest Earnings Date | 05/05/26 | 05/05/26 | 05/07/26 | 04/23/26 | 05/04/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 44.09 | 22.00 | 17.36 | 18.19 | 29.10 |